Top compounds associated with response to FITM1


Feature Type Standardized
Nominal ANOVA
mRNA Platin CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.017 0.8
mRNA Dasatinib GDSC1000 pan-cancer AAC 0.013 0.8
mRNA RAF265 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.0096 0.8
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0095 0.8
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.0098 0.8
mRNA CIL55 CTRPv2 pan-cancer AAC 0.021 0.8
mRNA neratinib CTRPv2 pan-cancer AAC -0.0096 0.8
mRNA YM-155 CTRPv2 pan-cancer AAC 0.01 0.8
Download CSV